TITLE

Management of the chest in cystic fibrosis

AUTHOR(S)
Dinwiddie, R.
PUB. DATE
January 1986
SOURCE
Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p6
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the importance of adequate care of the chest in the management of a patient with cystic fibrosis (CF). The role of allergy in lung disease is discussed, as well as the regular surveillance of the CF patient. The modes of lung management can be grouped into pulmonary clearance, antibiotic therapy, anti-asthma treatment and use of inhaled mucolytics.
ACCESSION #
23996701

 

Related Articles

  • State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Chmiel, James F.; Davis, Pamela B. // Respiratory Research;2003, Vol. 4, p1 

    Cystic Fibrosis (CF) lung disease, which is characterized by airway obstruction, chronic bacterial infection, and an excessive inflammatory response, is responsible for most of the morbidity and mortality. Early in life, CF patients become infected with a limited spectrum of bacteria, especially...

  • European Healthcare Spending Affects Cystic Fibrosis Survival. Baney, Jack // Pulmonary Reviews;Apr2010, Vol. 15 Issue 4, p7 

    The article presents a study by the University of Dundee in Scotland which showed that patients with cystic fibrosis tended to live longer in countries that belonged to the European Union (EU) than those who live in non-EU countries. Researchers hypothesized that cystic fibrosis patients would...

  • Hypertonic Saline Doesn't Reduce Pulmonary Exacerbation Rates in Young CF Patients. Peller, Beth Tansey // Pulmonary Reviews;Jul2012, Vol. 17 Issue 6, p16 

    The article discusses a study on hypertonic saline and exacerbation rates in young cystic fibrosis (CF) patients. According to the study, inhaled hypertonic saline (IHS) for the treatment of CF in infants and children younger than 6 did not reduce the rate of pulmonary exacerbation. Prior...

  • New therapy marks a milestone in fight against cystic fibrosis.  // Biomedical Market Newsletter;11/9/2011, Vol. 21, p610 

    The article reports on a study which examines the impact of the drug ivacaftor on patients with cystic fibrosis (CF). Findings reveal that the said drug can significantly improve the lung function of CF-affected persons. It notes that the discovery can open new opportunities for the treatment of CF.

  • Surfactant Protein A - From Genes to Human Lung Diseases. Heinrich, S.; Hartl, D.; Griese, M. // Current Medicinal Chemistry;2006, Vol. 13 Issue 27, p3239 

    Surfactant associated protein-A (SP-A) is the most abundant pulmonary surfactant protein and belongs to the family of innate host defense proteins termed collectins. Besides pulmonary host defense, SP-A is also involved in the formation of pulmonary surfactant, as it is essential for the...

  • Significance of Recurrent Hemoptysis in Allergic Asthma. Marks, Meyer B. // Clinical Pediatrics;Aug1971, Vol. 10 Issue 8, p479 

    This article presents information on a case study related to recurrent hemoptysis in allergic asthma. Children who aspirate foreign bodies may wheeze. Often the breath sounds are transmitted throughout the lung fields. Researchers H.E. Williams and P.D. Phelan studied 189 children who had...

  • γδ T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-α and IFN-γ-producers in response to Pseudomonas aeruginosa. Raga, Salvador; Julià, M. Rosa; Crespí, Catalina; Figuerola, Joan; Martínez, Natalia; Milà, Joan; Matamoros, Núria // Respiratory Research;2003, Vol. 4, p1 

    Background: γδ T cells have an important immunoregulatory and effector function through cytokine release. They are involved in the responses to Gram-negative bacterium and in protection of lung epithelium integrity. On the other hand, they have been implicated in airway inflammation....

  • Cystic Fibrosis.  // Current Medical Literature: Respiratory Medicine;2006, Vol. 20 Issue 3, p82 

    The article comments on several researches about cystic fibrosis. These include the "Impact of pregnancy on women with cystic fibrosis," which suggested that women with such disease who became pregnant experience similar respiratory and health trends as those observed in non-pregnant women....

  • Living in limbo - patients with cystic fibrosis waiting for transplant. Macdonald, Kath // British Journal of Nursing;5/25/2006, Vol. 15 Issue 10, p566 

    Lung transplant for patients with end-stage cystic fibrosis (CF) in the UK is recognized as the only successful treatment for CF patients with advanced lung disease. This study uses an exploratory approach to examine how patients with CF and their carers cope with the rigours of chronic illness...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics